AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glycihold-M1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Cadsol Life Sciences LLP

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glycihold-M1 Tablet PR

Diabex Duo tablets are antidiabetic medications combining two agents to manage type 2 diabetes in adults. They help regulate blood glucose. Diabex Duo should be taken with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continue taking this medication as prescribed, even if feeling well or experiencing controlled glucose levels. Discontinuing without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and have readily available glucose sources (e.g., sugary snacks, juice). Alcohol increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. Do not use Diabex Duo if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver disease. Inform your doctor of any heart history before starting this medication; it may be unsuitable. Pregnant or breastfeeding individuals should seek medical advice before use. Regular blood glucose monitoring and potential blood tests (blood cell counts, liver function) will be necessary as directed by your physician.

Uses of Glycihold-M1 Tablet PR

Managing type 2 diabetes

Major Benefits of Glycihold-M1 Tablet PR:

Follow your physician's instructions or refer to the product label for guidance before administering. Consume Glycihold-M1 Tablet PR with a meal.

Common Side effects of Glycihold-M1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glycihold-M1 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidance. Administer Glycihold-M1 Tablet PR with meals.

How Glycihold-M1 Tablet PR works:

Glycihold-M1 PR tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glycihold-M1 Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glycihold-M1 Tablet PR during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glycihold-M1 Tablet PR are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with severely low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glycihold-M1 Tablet PR, potentially requiring dosage modification. A physician's consultation is recommended. Glycihold-M1 Tablet PR is contraindicated in patients with severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glycihold-M1 Tablet PR to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, Glycihold-M1 Tablet PR should initially be administered at a reduced dosage. Its use is contraindicated in those with severe liver disease.

What if you forget to take Glycihold-M1 Tablet PR :

Should you forget to take a Glycihold-M1 Tablet PR, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Glycihold-M1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glycihold-M1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glycihold-M1 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glycihold-M1 Tablet PR and seek immediate medical attention.
Glycihold-M1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Glycihold-M1 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glycihold-M1 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glycihold-M1 Tablet PR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glycihold-M1 Tablet PR and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glycihold-M1 Tablet PR
86
MRP 105
18% off